Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Drug development in critical times.

Bain LJ.

NeuroRx. 2006 Oct;3(4):540-3. No abstract available.

2.

Spinal muscular atrophy: a test case for drug development in orphan diseases.

Bain LJ.

NeuroRx. 2006 Oct;3(4):535-9. No abstract available.

3.
4.
5.

Behavioral tests for preclinical intervention assessment.

Schallert T.

NeuroRx. 2006 Oct;3(4):497-504. Review.

6.

Two-photon imaging of synaptic plasticity and pathology in the living mouse brain.

Grutzendler J, Gan WB.

NeuroRx. 2006 Oct;3(4):489-96. Review.

7.

Imaging motor recovery after stroke.

Yozbatiran N, Cramer SC.

NeuroRx. 2006 Oct;3(4):482-8. Review.

8.

Noninvasive brain stimulation in stroke rehabilitation.

Webster BR, Celnik PA, Cohen LG.

NeuroRx. 2006 Oct;3(4):474-81. Review.

9.
10.

Growth factors and stroke.

Greenberg DA, Jin K.

NeuroRx. 2006 Oct;3(4):458-65. Review.

11.
12.

Exercise rehabilitation after stroke.

Ivey FM, Hafer-Macko CE, Macko RF.

NeuroRx. 2006 Oct;3(4):439-50. Review.

13.

Activity-based therapies.

Dromerick AW, Lum PS, Hidler J.

NeuroRx. 2006 Oct;3(4):428-38. Review.

14.

Plasticity.

Nudo RJ.

NeuroRx. 2006 Oct;3(4):420-7. Review.

15.

Translational issues in neurorehabilitation.

Chopp M, Weinrich M.

NeuroRx. 2006 Oct;3(4):418-9. No abstract available.

16.

Changing the name of the journal.

Faden AI.

NeuroRx. 2006 Oct;3(4):417. No abstract available.

17.

The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Ma'ayan A, Gardiner K, Iyengar R.

NeuroRx. 2006 Jul;3(3):396-406. Review.

18.

Utility of correlation measures in analysis of gene expression.

Almudevar A, Klebanov LB, Qiu X, Salzman P, Yakovlev AY.

NeuroRx. 2006 Jul;3(3):384-95. Review.

19.
20.

The application of NMR-based metabonomics in neurological disorders.

Holmes E, Tsang TM, Tabrizi SJ.

NeuroRx. 2006 Jul;3(3):358-72. Review.

Supplemental Content

Loading ...
Support Center